May 07, 2020
Global Corticosteroids Therapy Industry & COVID-19, Forecast to 2030
Apr 10, 2020
Lilly Begins Clinical Testing of Therapies for COVID-19
Mar 16, 2020
The Global Shingles Vaccine Market is expected to grow by USD 1.08 bn during 2020-2024, progressing at a CAGR of 7% during the forecast period
Aug 26, 2019
NanoViricides, Inc. Has Filed its Annual Report, Company Advancing Rapidly Towards First IND
Aug 23, 2019
Lilly Announces Top-Line Phase 3 Results for Oral JAK Inhibitor Baricitinib, in Combination with Topical Corticosteroids in Adult Patients with Moderate to Severe Atopic Dermatitis
Aug 06, 2019
IBHS Tests Shingle Performance Against Hail, Shares Scorecard
Jun 06, 2019
BioPlus Specialty Pharmacy Dispensing Non-opioid Pain Medication Qutenza® (Capsaicin) 8% Patch in Exclusive Relationship
Apr 16, 2019
NanoViricides Submits Pre-IND Briefing Documents to the US FDA
Mar 26, 2019
NanoViricides has Requested a Pre-IND Meeting with the US FDA
Mar 05, 2019
NanoViricides Reports Excellent Safety Profile of Its First Drug Candidate in Dermal Treatment Study
Feb 27, 2019
NanoViricides Announces $2.5 Million Financing in a Registered Direct Offering
Feb 26, 2019
NanoViricides Reaches an Agreement on Terms of License for Shingles Virus Drug Development
Feb 19, 2019
NanoViricides Files Quarterly Report for Period Ending December 31, 2018 - HerpeCide Drug Candidate Progressing in IND-Enabling Studies Towards Clinical Trials
Feb 11, 2019
NanoViricides President Dr. Diwan to Present at the BIO CEO & Investor 2019 Event in New York City Tomorrow Feb 12th at 2:30pm
Feb 04, 2019
Lilly Announces Top-Line Phase 3 Results for Baricitinib in Patients with Moderate to Severe Atopic Dermatitis
Feb 04, 2019
NanoViricides Has Initiated IND-Enabling Safety/Toxicology Studies for Its First Drug Candidate Moving towards Human Clinical Trials
Jan 31, 2019
Okogen Initiates Phase 2 Clinical Trial (RUBY) of OKG-0301 in Patients with Acute Adenoviral Conjunctivitis
Jan 14, 2019
Saol Therapeutics Announces CDC has Updated Information Related to Use and Availability of VARIZIG® (Varicella Zoster Immune Globulin [Human])
Nov 26, 2018
NanoViricides Files Quarterly Report for Period Ending September 30, 2018
Nov 05, 2018
Grünenthal Acquires Global Rights for Qutenza®